299 related articles for article (PubMed ID: 27546441)
1. The Impact of Collagenase Clostridium histolyticum Introduction on Dupuytren Treatment Patterns in the United States.
Zhao JZ; Hadley S; Floyd E; Earp BE; Blazar PE
J Hand Surg Am; 2016 Oct; 41(10):963-968. PubMed ID: 27546441
[TBL] [Abstract][Full Text] [Related]
2. Collagenase clostridium histolyticum for dupuytren contracture: patterns of use and effectiveness in clinical practice.
Peimer CA; Skodny P; Mackowiak JI
J Hand Surg Am; 2013 Dec; 38(12):2370-6. PubMed ID: 24140362
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies.
Witthaut J; Jones G; Skrepnik N; Kushner H; Houston A; Lindau TR
J Hand Surg Am; 2013 Jan; 38(1):2-11. PubMed ID: 23218556
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
Badalamente MA; Hurst LC; Benhaim P; Cohen BM
J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
[TBL] [Abstract][Full Text] [Related]
5. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
[TBL] [Abstract][Full Text] [Related]
6. Pain Associated With Treatment of Dupuytren Contracture With Collagenase Clostridium histolyticum.
Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P; Fikri-Benbrahim N; Franco-Ferrando N; Peimer CA
J Hand Surg Am; 2017 Feb; 42(2):e109-e114. PubMed ID: 28160905
[TBL] [Abstract][Full Text] [Related]
7. Development of Collagenase Treatment for Dupuytren Disease.
Badalamente MA; Hurst LC
Hand Clin; 2018 Aug; 34(3):345-349. PubMed ID: 30012294
[TBL] [Abstract][Full Text] [Related]
8. The Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand: A Prospective, Multicenter Study.
Gaston RG; Larsen SE; Pess GM; Coleman S; Dean B; Cohen BM; Kaufman GJ; Tursi JP; Hurst LC
J Hand Surg Am; 2015 Oct; 40(10):1963-71. PubMed ID: 26216077
[TBL] [Abstract][Full Text] [Related]
9. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Tursi JP; Cohen B; Kaufman GJ; Lindau T
J Hand Surg Am; 2013 Jan; 38(1):12-22. PubMed ID: 23200951
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Recurrent Dupuytren Contracture in Joints Previously Effectively Treated With Collagenase Clostridium histolyticum.
Bear BJ; Peimer CA; Kaplan FTD; Kaufman GJ; Tursi JP; Smith T
J Hand Surg Am; 2017 May; 42(5):391.e1-391.e8. PubMed ID: 28341067
[TBL] [Abstract][Full Text] [Related]
11. The use of Collagenase Clostridium Histolyticum in the management of Dupuytren's contracture-outcomes of a pilot study in a District General Hospital setting.
Murphy LE; Murphy KM; Kilpatrick SM; Thompson NW
Ulster Med J; 2017 May; 86(2):94-98. PubMed ID: 29535479
[TBL] [Abstract][Full Text] [Related]
12. Outcome of Dupuytren Contractures After Collagenase Clostridium Histolyticum Injection: A Single-institution Experience.
Hwee YK; Park D; Vinas M; Litts C; Friedman D
Ann Plast Surg; 2017 Aug; 79(2):145-148. PubMed ID: 28604542
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial.
Costas B; Coleman S; Kaufman G; James R; Cohen B; Gaston RG
BMC Musculoskelet Disord; 2017 Aug; 18(1):374. PubMed ID: 28854973
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures.
Coleman S; Gilpin D; Kaplan FT; Houston A; Kaufman GJ; Cohen BM; Jones N; Tursi JP
J Hand Surg Am; 2014 Jan; 39(1):57-64. PubMed ID: 24315486
[TBL] [Abstract][Full Text] [Related]
15. The treatment of Dupuytren disease.
Desai SS; Hentz VR
J Hand Surg Am; 2011 May; 36(5):936-42. PubMed ID: 21527148
[TBL] [Abstract][Full Text] [Related]
16. Dupuytren Cords Do Not Undergo Significant Histopathological Change After Collagenase Clostridium Histolyticum Injection.
Guo M; Yang K; Kock ND; Daley R; Dzwierzynski W; LoGiudice J; Hettinger P; Best C; Argenta A
Hand (N Y); 2023 Sep; 18(6):912-917. PubMed ID: 35081825
[No Abstract] [Full Text] [Related]
17. A comparison of percutaneous needle fasciotomy and collagenase injection for dupuytren disease.
Nydick JA; Olliff BW; Garcia MJ; Hess AV; Stone JD
J Hand Surg Am; 2013 Dec; 38(12):2377-80. PubMed ID: 24060510
[TBL] [Abstract][Full Text] [Related]
18. Trends in the Treatment of Dupuytren Disease in the United States Between 2007 and 2014.
Lipman MD; Carstensen SE; Deal DN
Hand (N Y); 2017 Jan; 12(1):13-20. PubMed ID: 28082837
[No Abstract] [Full Text] [Related]
19. Limited Fasciectomy Versus Collagenase Clostridium histolyticum for Dupuytren Contracture: A Propensity Score Matched Study of Single Digit Treatment With Minimum 5 Years of Telephone Follow-Up.
Gruber JS; Zhang D; Janssen SJ; Blazar P; Jupiter JB; Earp BE
J Hand Surg Am; 2021 Oct; 46(10):888-895. PubMed ID: 34275684
[TBL] [Abstract][Full Text] [Related]
20. A
Pess GM; Sundbom M; Wilson K; Lindqvist D; Dahlin LB
J Plast Surg Hand Surg; 2018 Oct; 52(5):301-306. PubMed ID: 30039732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
